Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients

Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients

The molecular mechanisms underlying chemoresistance in some newly diagnosed multiple myeloma (MM) patients receiving standard therapies (lenalidomide, bortezomib, and dexamethasone) are poorly understood. Identifying clinically relevant gene networks associated with death due to MM may uncover novel...

Full description

Bibliographic Details
Main Authors: Olayinka O. Adebayo, Eric B. Dammer, Courtney D. Dill, Adeyinka O. Adebayo, Saheed O. Oseni, Ti’ara L. Griffen, Adaugo Q. Ohandjo, Fengxia Yan, Sanjay Jain, Benjamin G. Barwick, Rajesh Singh, Lawrence H. Boise, James W. Lillard, Jr.
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
multiple myeloma
chemoresistance
ROC
log-rank
Kaplan–Meier
WGCNA
Online Access:https://www.mdpi.com/2072-6694/14/9/2228

Internet

https://www.mdpi.com/2072-6694/14/9/2228

Similar Items